SBC Medical Group (NASDAQ:SBC) Reaches New 1-Year High – What’s Next?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) reached a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $5.61 and last traded at $5.4040, with a volume of 39,904 shares trading hands. The stock had previously closed at $5.39.

Analysts Set New Price Targets

SBC has been the topic of several research reports. Wall Street Zen upgraded shares of SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Monday, October 5th. Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday. Finally, BTIG Research reissued a “buy” rating and set a $8.00 price objective on shares of SBC Medical Group in a report on Thursday, August 13th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, SBC Medical Group currently has an average rating of “Moderate Buy” and an average target price of $8.50.

SBC Medical Group Price Performance

The stock has a market cap of $544.69 million, a P/E ratio of 11.29, a price-to-earnings-growth ratio of 2.44 and a beta of 0.56. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09. The business’s 50-day simple moving average is $4.31 and its two-hundred day simple moving average is $3.69.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The company had revenue of $49.19 million for the quarter, compared to the consensus estimate of $45.37 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. Sell-side analysts expect that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

Institutional Investors Weigh In On SBC Medical Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Williams & Novak LLC lifted its holdings in shares of SBC Medical Group by 31.2% in the second quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after buying an additional 4,449 shares in the last quarter. Williams & Novak Wealth Management LLC grew its stake in SBC Medical Group by 40.9% during the third quarter. Williams & Novak Wealth Management LLC now owns 26,330 shares of the company’s stock valued at $130,000 after acquiring an additional 7,644 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in SBC Medical Group during the 1st quarter worth approximately $43,000. Bank of America Corp DE bought a new stake in SBC Medical Group during the 2nd quarter worth approximately $35,000. Finally, State Street Corp lifted its stake in SBC Medical Group by 59.7% in the 2nd quarter. State Street Corp now owns 49,239 shares of the company’s stock worth $152,000 after purchasing an additional 18,400 shares in the last quarter. 60.82% of the stock is currently owned by institutional investors.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.